[
    [
        {
            "time": "",
            "original_text": "病毒防治概念股午后继续走弱，博雅生物、健帆生物等领跌",
            "features": {
                "keywords": [
                    "病毒防治",
                    "概念股",
                    "走弱",
                    "博雅生物",
                    "健帆生物",
                    "领跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "病毒防治概念股午后继续走弱，博雅生物、健帆生物等领跌",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "健帆生物半年度业绩亮眼却遭机构连续减持 减持股份数量较大",
            "features": {
                "keywords": [
                    "健帆生物",
                    "半年度业绩",
                    "亮眼",
                    "机构",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物半年度业绩亮眼却遭机构连续减持 减持股份数量较大",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]